Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SRPT > SEC Filings for SRPT > Form 8-K on 9-Jan-2012All Recent SEC Filings

Show all filings for AVI BIOPHARMA INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for AVI BIOPHARMA INC


9-Jan-2012

Regulation FD Disclosure


Item 7.01 Regulation FD Disclosure.

Chris Garabedian, President and Chief Executive Officer of AVI BioPharma, Inc. (the "Company"), will be conducting meetings with several investors attending the 30th Annual J.P. Morgan Healthcare Conference in San Francisco from January 9, 2012 through January 12, 2012. At these meetings, Mr. Garabedian is prepared to provide the following unaudited preliminary information regarding the Company's 2011 financial results:

The Company had cash and cash equivalents of $39.9 million as of December 31, 2011;

Revenues for the year ended December 31, 2011 are anticipated to be at or above the midpoint of the Company's previous revenue guidance of $40.0 to $50.0 million; and

Cash burn for the year ended December 31, 2011 is anticipated to be $26.0 million. The Company's cash burn is anticipated to be lower than the guidance provided in November 2011 due primarily to the increase in various third party billings and the receipt of associated government funding related to the Company's Ebola and Marburg government contract, which the Company had previously anticipated to occur in 2012.

Management will provide financial guidance for 2012 in connection with the Company's 2011 year-end earnings call.

The information in this Current Report on Form 8-K is being furnished under Item 7.01 and shall not be deemed to be filed for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 (the "Securities Act") or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

This Current Report on Form 8-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements are identified by such words as "believe," "expect," "anticipate" and words of similar import and are based on current expectations that involve risks and uncertainties, such as the Company's plans, objectives, expectations and intentions. All statements other than historical or current facts are forward-looking statements, including, without limitation, statements about the Company's anticipated 2011 financial results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. These statements, like all statements in this report, speak only as of their date.

-2-


  Add SRPT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SRPT - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.